Fractalkine, a CX3C Chemokine, Act as a Mediator of Ocular Angiogenesis
Clinical trial NCT00728598 · COMPLETED
Trial details
- NCT number
- NCT00728598
- Sponsor
- National Taiwan University Hospital
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 1998-01-01
- Primary completion
- 1998-12-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.